These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19307452)

  • 1. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
    Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
    J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity.
    Pieper GM; Nilakantan V; Halligan NL; Khanna AK; Hilton G; Vásquez-Vivar J
    Biochem J; 2005 Nov; 391(Pt 3):541-7. PubMed ID: 16000090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection.
    Cai B; Roy DK; Sciacca R; Michler RE; Cannon PJ
    Int J Cardiol; 1995 Jul; 50(3):243-51. PubMed ID: 8537148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection.
    Pieper GM; Halligan NL; Hilton G; Konorev EA; Felix CC; Roza AM; Adams MB; Griffith OW
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3125-30. PubMed ID: 12624190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase.
    Nilakantan V; Halligan NL; Nguyen TK; Hilton G; Khanna AK; Roza AM; Johnson CP; Adams MB; Griffith OW; Pieper GM
    J Heart Lung Transplant; 2005 Oct; 24(10):1591-9. PubMed ID: 16210135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes.
    Ionova IA; Vásquez-Vivar J; Whitsett J; Herrnreiter A; Medhora M; Cooley BC; Pieper GM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2178-87. PubMed ID: 18835915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
    Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection.
    Ionova IA; Vásquez-Vivar J; Cooley BC; Khanna AK; Whitsett J; Herrnreiter A; Migrino RQ; Ge ZD; Regner KR; Channon KM; Alp NJ; Pieper GM
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H88-96. PubMed ID: 20418482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical change in antioxidant enzyme gene expression and activity in acute cardiac rejection: role of inducible nitric oxide synthase.
    Nilakantan V; Zhou X; Hilton G; Roza AM; Adams MB; Johnson CP; Pieper GM
    Mol Cell Biochem; 2005 Feb; 270(1-2):39-47. PubMed ID: 15792352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of COX-2 during cardiac allograft rejection.
    Yang X; Ma N; Szabolcs MJ; Zhong J; Athan E; Sciacca RR; Michler RE; Anderson GD; Wiese JF; Leahy KM; Gregory S; Cannon PJ
    Circulation; 2000 Feb; 101(4):430-8. PubMed ID: 10653836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.
    Pieper GM; Nilakantan V; Chen M; Zhou J; Khanna AK; Henderson JD; Johnson CP; Roza AM; Szabó C
    J Pharmacol Exp Ther; 2005 Jul; 314(1):53-60. PubMed ID: 15784653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNI-1493 prolongs survival and reduces myocyte loss, apoptosis, and inflammation during rat cardiac allograft rejection.
    Yang X; Szabolcs M; Minanov O; Ma N; Sciacca RR; Bianchi M; Tracey KJ; Michler RE; Cannon PJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):146-55. PubMed ID: 9676735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection.
    Szabolcs MJ; Sun J; Ma N; Albala A; Sciacca RR; Philips GB; Parkinson J; Edwards N; Cannon PJ
    Circulation; 2002 Oct; 106(18):2392-6. PubMed ID: 12403672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
    Pieper GM; Nilakantan V; Zhou X; Khanna AK; Johnson CP; Roza AM; Adams MB; Hilton G; Felix CC
    J Pharmacol Exp Ther; 2005 Feb; 312(2):774-9. PubMed ID: 15347735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase.
    Szabolcs M; Michler RE; Yang X; Aji W; Roy D; Athan E; Sciacca RR; Minanov OP; Cannon PJ
    Circulation; 1996 Oct; 94(7):1665-73. PubMed ID: 8840859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats.
    An J; Du J; Wei N; Xu H; Pritchard KA; Shi Y
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1783-91. PubMed ID: 19717731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergence in regulation of nitric-oxide synthase and its cofactor tetrahydrobiopterin by tumor necrosis factor-alpha. Ceramide potentiates nitric oxide synthesis without affecting GTP cyclohydrolase I activity.
    Vann LR; Twitty S; Spiegel S; Milstien S
    J Biol Chem; 2000 May; 275(18):13275-81. PubMed ID: 10788433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of GTP cyclohydrolase I and inducible nitric oxide synthase mRNAs in mouse osteoblastic cells activated by proinflammatory cytokines.
    Togari A; Arai M; Mogi M; Kondo A; Nagatsu T
    FEBS Lett; 1998 May; 428(3):212-6. PubMed ID: 9654136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.